KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Debt Ratio (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Debt Ratio for 17 consecutive years, with 0.15 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 14.06% to 0.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, down 14.06% year-over-year, with the annual reading at 0.15 for FY2025, 14.06% down from the prior year.
  • Debt Ratio hit 0.15 in Q4 2025 for Abbott Laboratories, down from 0.15 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 5.82 in Q4 2022 to a low of 0.15 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.59 across 5 years, with a median of 0.22 in 2022.
  • Biggest five-year swings in Debt Ratio: skyrocketed 148.16% in 2022 and later crashed 96.55% in 2023.
  • Year by year, Debt Ratio stood at 2.34 in 2021, then surged by 148.16% to 5.82 in 2022, then plummeted by 96.55% to 0.2 in 2023, then dropped by 13.47% to 0.17 in 2024, then fell by 14.06% to 0.15 in 2025.
  • Business Quant data shows Debt Ratio for ABT at 0.15 in Q4 2025, 0.15 in Q3 2025, and 0.16 in Q2 2025.